Next Article in Journal
A New Inflammatory Marker: Elevated Monocyte to HDL Cholesterol Ratio Associated with Smoking
Previous Article in Journal
Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma
Open AccessArticle

Enhanced Efficacy of High Dose Oral Vancomycin Therapy in Clostridium difficile Diarrhea for Hospitalized Adults Not Responsive to Conventional Oral Vancomycin Therapy: Antibiotic Stewardship Implications

1
Infectious Disease Division, NYU Winthrop Hospital, Mineola, NY 11501, USA
2
State University of New York, School of Medicine, Stony Brook, NY 11794, USA
3
Department of Pharmacy, Winthrop-University Hospital, Mineola, NY 11501, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2018, 7(4), 75; https://doi.org/10.3390/jcm7040075
Received: 7 March 2018 / Revised: 2 April 2018 / Accepted: 5 April 2018 / Published: 10 April 2018
(This article belongs to the Section Pharmacology)
Current therapy of Clostridium difficile diarrhea (CDD) is problematic. Optimal treatment for CDD remains oral vancomycin, but there is little data on oral vancomycin dosing regimens. The objective of this C. difficile diarrhea study was to compare the efficacy of “high dose” vancomycin, 500 mg (PO) q6h, as sole treatment and in those who after 72 h failed to respond to conventional doses of oral vancomycin, 125–250 mg (PO) q6h. Hospitalized adults with CDD were evaluated by various oral vancomycin regimens, i.e., a conventional dose group (125–250 mg (PO) q6h), a “high dose escalation” dose group (250 mg → 500 mg (PO) q6h), and a “high dose” group (500 mg (PO) q6h). Oral vancomycin treatment groups were compared by time to improvement, i.e., decrease in >50% of watery stools/day and duration of therapy. The high dose escalation and high dose oral vancomycin groups showed the most rapid resolution of diarrhea. There was marked decrease in stools/day after “high dose” vancomycin escalation from conventional dosing, i.e., 250 mg (PO) q6h → 500 mg (PO) q6h. This study demonstrated that “high dose” escalation or initial high dose oral vancomycin, i.e., 500 mg (PO) q6h was the most efficacious regimen for CDD. View Full-Text
Keywords: oral vancomycin; C. difficile diarrhea; oral vancomycin dosing regimens; metronidazole ineffectiveness oral vancomycin; C. difficile diarrhea; oral vancomycin dosing regimens; metronidazole ineffectiveness
Show Figures

Figure 1

MDPI and ACS Style

Cunha, B.A.; Sessa, J.; Blum, S. Enhanced Efficacy of High Dose Oral Vancomycin Therapy in Clostridium difficile Diarrhea for Hospitalized Adults Not Responsive to Conventional Oral Vancomycin Therapy: Antibiotic Stewardship Implications. J. Clin. Med. 2018, 7, 75.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop